-
Comparative Efficacy and Safety of Adjunctive CT-152 in Major Depressive Disorder: A Frequentist Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Real-World Evidence in FDA and EMA Regulatory Reviews: Insights on Its Role in Submission Packages and Approvals
Mar 10, 2025, 14:00 PM -
A European perspective on Health Resource Utilization (HRU) and Cost outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs in Individuals Who Discontinue Liraglutide and Who Switch from Liraglutide to Once-Weekly Injectable Semaglutide
Mar 10, 2025, 14:00 PM -
Absenteeism and Presenteeism Associated With Chronic Conditions in a Canadian Working Population
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Costs in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real World Data
Mar 10, 2025, 14:00 PM -
Trends in Attainment of the Kidney Health Evaluation for Patients With Diabetes Measure Among Insured Individuals in the US, 2021-2024
Mar 10, 2025, 14:00 PM -
Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Mar 10, 2025, 14:00 PM -
Building on ‘Contemporary Practice and Considerations for Real-World Data (RWD) Source Identification and Feasibility Assessment’: Mapping Feasibility Criteria Across 46 Real-World Evidence (RWE) Guidelines
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management
Mar 10, 2025, 14:00 PM -
Development and Psychometric Validation of Patient-Reported Outcome Measures for Masseter Muscle Prominence (MMP): The Lower Facial Shape Questionnaire
Mar 10, 2025, 14:00 PM -
Real-World Evidence on the Use of Secondary Prevention for People With ASCVD or CKD: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Rethinking Women's Health: Unpacking the 2024 Women's Health Research Roadmap With a Landscape Review of Clinical Outcome Assessments (COA), Health Agency Recommendations and Drug Label Claims With COA Related to Women's Health
Mar 10, 2025, 14:00 PM -
Considerations for Health Economic Modeling in Phenylketonuria (PKU): Insights From a Modified Delphi Panel
Mar 10, 2025, 14:00 PM -
Short- and Longer-Term Healthcare Resource Utilization and Related Costs of Stroke in the Brazilian Private Market from 2019 to 2023
Mar 10, 2025, 14:00 PM -
Sodium Glucose Co-Transporter 2 Inhibitor Exposure and the Risk of Congenital Malformations: Nationwide Birth Cohort Study
Mar 10, 2025, 14:00 PM -
Elephant in the Room: Gap Between the Awareness and Need for Psycho-Social Support for Czech Lymphoma Patients as Captured Through the Analyzes of Social and Traditional Media
Mar 10, 2025, 14:00 PM -
Economic Evaluation of NT-proBNP Testing to Facilitate Prevention of Heart Failure in Adults With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
A Retrospective Analysis of the Italian Medicines Agency’s Evaluation of Real-World Evidence in Innovativeness Assessments
Mar 10, 2025, 14:00 PM -
Enhanced Outcomes and Reduced Healthcare Utilization with Specialized Home Healthcare Service Providers for Ostomy and Urological Patients: Comparative Research with Pharmacy-Based Care
Mar 10, 2025, 14:00 PM
